Indian Pharma Market to Hit Rs 2.38 Lakh Crore by 2025: Pharmarack Report

Additionally, growing awareness of obesity treatments, a shift toward over-the-counter (OTC) products, and rising online sales significantly contribute to the changing market landscape.

Also Read: Indian Pharma Market Grows at 9.9 Percent, Vaccine Sales See Sharp Decline: Pharmatrac Report

Therapy-wise, cardiac and gastrointestinal segments are at the forefront of growth, with projected increases of 8.3% and 9.6%, respectively, in 2025. Other notable areas include respiratory therapies at 8.7% and anti-neoplastics at 9.8%. However, vaccines stand out as a declining category, expected to drop by 1.8% under the realistic scenario, highlighting segment-specific challenges.

Three scenarios—optimistic, realistic, and pessimistic—were explored to provide comprehensive insights. The optimistic scenario projects Rs. 239,893 crore (9% growth), driven by rapid adoption of new therapies, while the pessimistic scenario suggests Rs. 236,285 crore (7.4% growth), accounting for slower market adoption and other constraints.

Also Read: Indian Pharma Market Posts Robust 10.7 Percent Growth In November, Foracort Tops Sales: IQVIA